Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis

Rubbert-Roth, A; Enejosa, J; Pangan, AL; Haraoui, B; Rischmueller, M; Khan, N; Zhang, Y; Martin, N; Xavier, RM

Rubbert-Roth, A (corresponding author), Cantonal Clin St Gallen, Div Rheumatol, Rorschacher Str 95, CH-9007 St Gallen, Switzerland.

NEW ENGLAND JOURNAL OF MEDICINE, 2020; 383 (16): 1511

Abstract

BackgroundUpadacitinib is an oral selective Janus kinase inhibitor to treat rheumatoid arthritis. The efficacy and safety of upadacitinib as compared ......

Full Text Link